loading
前日終値:
$9.30
開ける:
$9.31
24時間の取引高:
190.25K
Relative Volume:
1.58
時価総額:
$139.09M
収益:
$166.88M
当期純損益:
$-74.18M
株価収益率:
-1.8974
EPS:
-5.07
ネットキャッシュフロー:
$1.14M
1週間 パフォーマンス:
-3.45%
1か月 パフォーマンス:
-1.38%
6か月 パフォーマンス:
-17.63%
1年 パフォーマンス:
-44.66%
1日の値動き範囲:
Value
$9.22
$9.645
1週間の範囲:
Value
$9.22
$10.01
52週間の値動き範囲:
Value
$7.8701
$18.37

Anika Therapeutics Inc Stock (ANIK) Company Profile

Name
名前
Anika Therapeutics Inc
Name
セクター
Healthcare (1137)
Name
電話
(781) 457-9000
Name
住所
32 WIGGINS AVENUE, BEDFORD, MA
Name
職員
288
Name
Twitter
Name
次回の収益日
2025-03-12
Name
最新のSEC提出書
Name
ANIK's Discussions on Twitter

ANIK を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
ANIK
Anika Therapeutics Inc
9.645 134.12M 166.88M -74.18M 1.14M -5.07
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
121.71 51.07B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.32 44.42B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.885 42.75B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
24.26 27.86B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
473.05 20.44B 3.08B 1.24B 1.07B 25.61

Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-17 開始されました B. Riley Securities Buy
2024-11-01 繰り返されました Barrington Research Outperform
2023-08-14 アップグレード Barrington Research Mkt Perform → Outperform
2023-03-07 ダウングレード Barrington Research Outperform → Mkt Perform
2022-11-09 アップグレード Barrington Research Mkt Perform → Outperform
2022-10-14 再開されました Stephens Equal-Weight
2022-03-09 ダウングレード Barrington Research Outperform → Mkt Perform
2022-03-09 ダウングレード Stephens Overweight → Equal-Weight
2021-11-16 開始されました Stephens Overweight
2021-07-16 開始されました UBS Neutral
2020-12-16 アップグレード Barrington Research Mkt Perform → Outperform
2020-05-08 ダウングレード Barrington Research Outperform → Mkt Perform
2020-01-21 アップグレード Sidoti Neutral → Buy
2020-01-10 アップグレード First Analysis Sec Outperform → Strong Buy
2019-11-05 開始されました BWS Financial Sell
2019-09-24 繰り返されました Barrington Research Outperform
2019-09-23 ダウングレード First Analysis Sec Strong Buy → Outperform
2019-07-25 アップグレード First Analysis Sec Neutral → Strong Buy
2019-02-22 ダウングレード First Analysis Sec Outperform → Neutral
2019-02-22 ダウングレード Sidoti Buy → Neutral
2018-07-27 アップグレード Barrington Research Mkt Perform → Outperform
2018-06-20 ダウングレード Barrington Research Outperform → Mkt Perform
2018-06-20 ダウングレード First Analysis Sec Overweight → Equal-Weight
2018-05-04 アップグレード Barrington Research Mkt Perform → Outperform
2018-02-23 ダウングレード Barrington Research Outperform → Mkt Perform
2018-01-24 アップグレード First Analysis Sec Equal-Weight → Overweight
2017-10-27 繰り返されました Barrington Research Outperform
2016-05-09 アップグレード Singular Research BUY - Long-Term → Buy
2016-04-27 ダウングレード Northland Capital Outperform → Market Perform
2016-02-26 繰り返されました Barrington Research Outperform
すべてを表示

Anika Therapeutics Inc (ANIK) 最新ニュース

pulisher
07:53 AM

How Anika Therapeutics Inc. stock responds to policy changes2025 Momentum Check & Reliable Intraday Trade Plans - newser.com

07:53 AM
pulisher
Nov 20, 2025

How Anika Therapeutics Inc. (AKP) stock reacts to Fed tighteningMarket Volume Report & Smart Money Movement Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Anika Therapeutics Inc. (AKP) stock deliver consistent EPS growthJuly 2025 Summary & Proven Capital Preservation Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Anika Therapeutics Inc. (AKP) stock hit analyst forecastsQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Anika Therapeutics Inc. stock benefit from sector rotationWeekly Investment Report & Fast Gain Stock Tips - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is Anika Therapeutics Inc. (AKP) stock a buy on weakness - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

How Anika Therapeutics Inc. (AKP) stock reacts to fiscal policies2025 Earnings Impact & Technical Entry and Exit Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Detecting support and resistance levels for Anika Therapeutics Inc.2025 Retail Activity & AI Driven Price Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How strong is Anika Therapeutics Inc. stock balance sheet2025 Technical Overview & Weekly High Return Stock Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Anika Therapeutics Inc. stock attractive after correctionJuly 2025 Opening Moves & Short-Term High Return Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Anika Therapeutics Inc. stock positioned for long term growthTrade Risk Summary & Real-Time Chart Pattern Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Anika Therapeutics Inc. stock supported by strong cash flowsEarnings Performance Report & Real-Time Stock Entry Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Anika Therapeutics Inc. (AKP) stock a buy before new product rolloutIPO Watch & Daily Profit Maximizing Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why Anika Therapeutics Inc. (AKP) stock stays resilient2025 Market Outlook & Reliable Breakout Forecasts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What is the fair value estimate for Anika Therapeutics Inc. (AKP) stock in 20252025 Volatility Report & AI Powered Trade Plan Recommendations - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Anika Therapeutics Inc. stock reach all time highs in 20252025 Breakouts & Breakdowns & Real-Time Market Sentiment Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is Anika Therapeutics Inc. (AKP) stock resilient in recession scenariosPortfolio Gains Report & Daily Growth Stock Investment Tips - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Is Anika Therapeutics Inc. stock undervalued vs historical averages2025 Investor Takeaways & Daily Stock Trend Watchlist - newser.com

Nov 18, 2025

Anika Therapeutics Inc (ANIK) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Anika Therapeutics Inc (ANIK) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
Nunes Anne
SVP, Chief Operations Officer
Mar 17 '25
Option Exercise
0.00
3,637
0
21,722
Colleran David
EVP, General Counsel, Corp Sec
Mar 17 '25
Option Exercise
0.00
6,448
0
49,847
Blanchard Cheryl R
President, CEO, Director
Mar 17 '25
Option Exercise
0.00
25,132
0
209,472
Nunes Anne
SVP, Chief Operations Officer
Mar 11 '25
Option Exercise
0.00
2,561
0
18,837
Colleran David
EVP, General Counsel, Corp Sec
Mar 11 '25
Option Exercise
0.00
7,663
0
45,649
Blanchard Cheryl R
President, CEO, Director
Mar 11 '25
Option Exercise
0.00
30,060
0
197,015
Nunes Anne
SVP, Chief Operations Officer
Mar 10 '25
Option Exercise
0.00
3,296
0
17,235
Colleran David
EVP, General Counsel, Corp Sec
Mar 10 '25
Option Exercise
0.00
5,465
0
39,590
Blanchard Cheryl R
President, CEO, Director
Mar 10 '25
Option Exercise
0.00
20,002
0
172,826
$34.62
price up icon 2.50%
$22.12
price up icon 4.19%
drug_manufacturers_specialty_generic RDY
$13.98
price up icon 0.65%
$10.52
price up icon 3.14%
$143.36
price up icon 3.11%
$472.95
price down icon 0.27%
大文字化:     |  ボリューム (24 時間):